EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis

M A Lyons iD, A Obregon-Henao, M E Ramey, A A Bauman, S Pauly, K Rossmassler, J Reid, B Karger, N D Walter, G T Robertson

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01010-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von M A Lyons und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Antitubercular Agents, Linezolid, Diarylquinolines, Mice, Inbred BALB C. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major challenge for tuberculosis (TB) drug development is to prioritize promising combination regimens from a large and growing number of possibilities. This includes demonstrating individual drug contributions to the activity of higher-order combinations. A BALB/c mouse TB infection model was used to evaluate the contributions of each drug and pairwise combination in the clinically relevant Nix-TB regimen [bedaquiline-pretomanid-linezolid (BPaL)] during the first 3 weeks of treatment at human equivalent doses. The rRNA synthesis (RS) ratio, an exploratory pharmacodynamic (PD) marker of ongoing Mycobacterium tuberculosis rRNA synthesis, together with solid culture CFU counts and liquid culture time to positivity (TTP) were used as PD markers of treatment response in lung tissue; and their time-course profiles were mathematically modeled using rate equations with pharmacologically interpretable parameters. Antimicrobial interactions were quantified using Bliss independence and Isserlis formulas. Subadditive (or antagonistic) and additive effects on bacillary load, assessed by CFU and TTP, were found for bedaquiline-pretomanid and linezolid-containing pairs, respectively. In contrast, subadditive and additive effects on rRNA synthesis were found for pretomanid-linezolid and bedaquiline-containing pairs, respectively. Additionally, accurate predictions of the response to BPaL for all three PD markers were made using only the single-drug and pairwise effects together with an assumption of negligible three-way drug interactions. The results represent an experimental and PD modeling approach aimed at reducing combinatorial complexity and improving the cost-effectiveness of in vivo systems for preclinical TB regimen development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsLinezolidDiarylquinolinesMice, Inbred BALB CMycobacterium tuberculosisDisease Models, AnimalAnimalsMiceFemaleNitroimidazolesDrug Therapy, CombinationLungTuberculosisMicrobial Sensitivity TestsTuberculosis, Pulmonary

Stichwörter der Autor:innen

RS ratiobedaquilineinteractionlinezolidmouse modelpharmacodynamicspretomanidtuberculosis

Substanzen

Antitubercular AgentsLinezolidbedaquilineDiarylquinolinespretomanidNitroimidazoles

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA.
  • Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.
  • Rocky Mountain Regional VA Medical Center, Aurora, Colorado, USA.

ORCID-Profile: M A Lyons

Förderung

  • BLRD VA
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • Bill and Melinda Gates Foundation
  • U.S. Department of Veterans Affairs

Zitieren

APA

Lyons, M. A., Obregon-Henao, A., Ramey, M. E., Bauman, A. A., Pauly, S., Rossmassler, K., Reid, J., Karger, B., Walter, N. D., & Robertson, G. T. (2024). Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01010-23

Vancouver

Lyons MA, Obregon-Henao A, Ramey ME, Bauman AA, Pauly S, Rossmassler K, et al. Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01010-23

BibTeX
@article{Lyons2024,
  author = {Lyons, M A and Obregon-Henao, A and Ramey, M E and Bauman, A A and Pauly, S and Rossmassler, K and Reid, J and Karger, B and Walter, N D and Robertson, G T},
  title = {Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01010-23}
}
Kostenlos starten →